Manuscripts
Showing 1543 manuscripts.
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Citation
Benjamin Johnston, Jeremiah D. Momper, Chelsea Krotje, Roger L. Shapiro, Lee Fairlie, Navdeep Thoofer, Risa Hoffman, James F. Rooney, Paul E. Sax, Lisa Frenkel, Sikhulile Moyo, K. Rivet Amico, Nahida Chakhtoura, Lameck Chinula, Jeffrey S. A. Stringer, Judith Currier, Gaerolwe Masheto, IMPAACT 2010/VESTED study team and investigators, Shahin Lockman, Violet Korutaro, Sean Brummel, Haseena Cassim, Lauren Ziemba, Blandina Mmbaga, Lynda Stranix-Chibanda, Esau Joao, Katie McCarthy, Sherika Hanley, Anne Coletti, Lynette Purdue, Patrick Jean-Philippe, Lewis Ball Holmes. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021. 397: 1276-92. PMID: 33812487Year
2021
Journal
Lancet
Study
IMPAACT 2010
IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation
Citation
Geri R Doneberg, Dorothy E. Dow, Suad Kapetanovic, Janice Buckley, Tebogo Jacqueline Kakhu, Portia Kamthunzi, Limbika A. Maliwichi, Tichaona Vhembo, Tariro Dianah Chawana, Teacler Nematadzira, Jennifer Libous, Nicole A. MontaƱez. IMPAACT 2016: Operationalizing HIV Intervention Adaptations to Inform the Science and Outcomes of Implementation. Frontiers in Reproductive Health. 2021. 3: 1-9. PMID: 36303985Year
2021
Journal
Frontiers in Reproductive Health
Study
IMPAACT 2016
Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial
Citation
PROMISE Study Team, Mauricio Pinilla, Mary Glenn Fowler, Kathleen George, George K. Siberry, Jim Aizire, Godwin Chipoka, Macpherson Mallewa, Megeshinee Naidoo, Teacler Nematadzira, Bangani Kusakara, Avy Violari, Tapiwa Mbengeranwa, Boniface Njau, Lee Fairlie, Gerard Theron, Mwangelwa Mubiana-Mbewe, Lynda Stranix-Chibanda, Sandhya Khadse, Camlin Tierney, Renee Browning. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One. 2021. 16: e0255250. PMID: 34415933Year
2021
Journal
PLoS One
Study
P1084s
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States
Citation
Betsy D Kennard, IMPAACT 2002 team, Graham J Emslie, Kathryn Lypen, Sarah Buisson, Adriana Weinberg, Laura B Whiteley, Shirley Traite, Chelsea Krotje, Lauren Harriff, Ellen Townley, Amber Bunch, Murli Purswani, Ray Shaw, Stephen A Spector, Larry K Brown, Allison Agwu, Miriam Chernoff, David E Shapiro. Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States. Journal of Acquired Immune Deficiency Syndromes. 2021. 88(5): 497-505. PMID: 34483297Year
2021
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2002
Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa
Citation
Violet Korutaro, Clemensia Nakabiito, Maysebole Masenya , Kathryn Lypen , Emily Brown, Mustafa E Ibrahim, Jenna Yager, Lubbe Wiesner, Benjamin Johnston, Lynda Stranix-Chibanda, K Rivet Amico , Peter L Anderson, James F Rooney , Deborah Kacanek, Nahida Chakhtoura, Sybil Hosek, Hans M L Spiegel, Sharon Huang, Benjamin H Chi, Teacler G Nematadzira, IMPAACT 2009 team, Frank Taulo. Tenofovir diphosphate concentrations in dried blood spots from pregnant and postpartum adolescent and young women receiving daily observed pre-exposure prophylaxis in sub-Saharan Africa. Clinical Infectious Diseases. 2021. PMID: 33341883Year
2021
Journal
Clinical Infectious Diseases
Study
IMPAACT 2009
Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial
Citation
Lynne Mofenson, James V. Lavery, Grace John-Stewart, Patricia Flynn, Gerhard Theron, Shrikhant I. Bangdiwala, Dhayendre Moodley, Lameck Chinula, Lee Fairlie, Tumalano Sekoto, Tebogo J. Kakhu, Avy Violari, Sufia Dadabhai, Katie McCarthy, Seema K. Shah, Mary Glenn Fowler, Alex John London. Ethically designing research to inform multidimensional, rapidly evolving policy decisions: Lessons learned from the PROMISE HIV Perinatal Prevention Trial. Clinical Trials. 2021. 18: 681-689. PMID: 34524048Year
2021
Journal
Clinical Trials
Study
1077HS, 1077FF, 1077BF
SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.
Citation
Hanna J, Spector SA, Campbell GR, To RK. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway.. iScience. 2021. 24: 102295. PMID: 33718825Year
2021
Journal
iScience
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
Citation
Lauren Ziemba, Anne Coletti, Renee Browning, Francesca Aweeka, John Moye, Philippa Musoke, Bobbie Graham, Christina Reding, Diane Costello, Jennifer Norman, Lubbe Wiesner, Emma Hughes, Meghan E. Whalen, Lynette Purdue, Blandina Theophil Mmbaga, Portia Kamthunzi, Rachel Kawalazira, Maxensia Owor, Kusum Nathoo, Camlin Tierney, Sarah Bradford. Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092. Pediatric Infectious Disease Journal. 2021. PMID: 33464021Year
2021
Journal
Pediatric Infectious Disease Journal
Study
P1092
Live-attenuated vaccines prevent respiratory syncytial virus (RSV)-associated illness in young children
Citation
Elizabeth J. MacFarland, Coleen K. Cunningham, Petronella Muresan, Charlotte Perlowski, Jennifer Libous, Stephen A. Spector, Ram Yogev, Mariam Aziz, Suzanne Woods, Kimberli Wanionek, Peter L. Collins, Ursula J. Buchholz, Ruth A. Karron, Jessica E. Atwell. Live-attenuated vaccines prevent respiratory syncytial virus (RSV)-associated illness in young children. American Journal of Respiratory and Critical Care Medicine. 2021. 203: 594-603. PMID: 32871092Year
2021
Journal
American Journal of Respiratory and Critical Care Medicine
Study
IMPAACT 2011, IMPAACT 2012, IMPAACT 2013, P1114, IMPAACT 2000
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants
Citation
Petronella Muresan, Adrian McDermott, Edmund Capperelli, John Mascola, Charlotte Perlowski, Barney Graham, Patricia Morgan, IMPAACT P1112 Team, Betsy Smith, Rohan Hazra, Lynette Purdue, Paul Harding, Gerhard Theron, Hilda Mujuru, Allison Agwu, Murli Purswani, Mobeen Rathore, Britta Flach, Elizabeth McFarland, Alison Taylor, Coleen Cunningham, Bob Lin. Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants. Journal of Infectious Diseases. 2021. 224: 1916-1924. PMID: 34009371Year
2021
Journal
Journal of Infectious Diseases
Study
P1112